• Avidity Biosciences looks to RNA therapeutics as investors weigh long-term potential AD HOC NEWS Tue, 07 Jul 2026 20:24:28 GMT
• myotonic dystrophy pipeline 2026: key companies, moa, roa, and clinical trials evaluation by delveinsight | dyne therapeutics, avi... Barchart.com Tue, 30 Jun 2026 07:42:29 GMT
• avidity biosciences inc (rna) valuation: pe, pb & fair value analysis TradingKey Fri, 26 Jun 2026 07:51:13 GMT
• avidity biosciences ord shs (rnam) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 10:18:51 GMT
• avidity biosciences inc (rna) financial health: profitability & balance sheet analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• avidity biosciences stock - long-term strategy around rna therapeutics AD HOC NEWS Sat, 20 Jun 2026 12:47:43 GMT
• avidity biosciences ord shs (rnam) technical analysis: support, resistance, indicators & moving averages TradingKey Sat, 20 Jun 2026 06:47:41 GMT
• avidity biosciences inc (rna) risk assessment: volatility, financial risk & investment risk TradingKey Fri, 19 Jun 2026 05:21:15 GMT
• avidity biosciences inc (rna) earnings forecast: future eps & revenue growth estimates TradingKey Fri, 19 Jun 2026 04:53:20 GMT
• avidity biosciences inc (rna) valuation: pe, pb & fair value analysis TradingKey Fri, 19 Jun 2026 02:50:53 GMT
• avidity biosciences inc (rna) financial health: profitability & balance sheet analysis TradingKey Fri, 19 Jun 2026 01:56:57 GMT
• avidity biosciences inc (rna) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 19 Jun 2026 01:44:52 GMT
• avidity biosciences ord shs (rnam) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 10:23:38 GMT
• avidity biosciences ord shs (rnam) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 10:22:10 GMT
• avidity biosciences ord shs (rnam) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 10:17:15 GMT
• avidity biosciences ord shs (rnam) institutional confidence TradingKey Thu, 18 Jun 2026 09:55:53 GMT
• avidity biosciences ord shs (rnam) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 09:53:58 GMT
• avidity biosciences ord shs (rnam) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 09:51:56 GMT
• avidity biosciences ord shs (rnam) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 08:54:26 GMT
• avidity biosciences inc (rna) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:47:20 GMT
• avidity biosciences inc (rna) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:47:11 GMT
• avidity biosciences inc (rna) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:18:48 GMT
• novartis $12bn bet on avidity well placed after mid-stage fshd win MSN Sat, 13 Jun 2026 17:45:06 GMT
• Novartis' phase 1/2 win tees up regulatory talks about dystrophy drug from $12B Avidity takeover Fierce Biotech Fri, 12 Jun 2026 07:00:00 GMT
• Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win BioSpace Fri, 12 Jun 2026 07:00:00 GMT
• muscular dystrophy sirna from novartis' buyout of avidity meets biomarker endpoints FirstWord Pharma Thu, 11 Jun 2026 20:26:15 GMT
• Novartis RNA drug acquired in $12B Avidity deal notches a trial win BioPharma Dive Thu, 11 Jun 2026 07:00:00 GMT
• Novartis $12bn bet on Avidity well placed after mid-stage FSHD win Clinical Trials Arena Thu, 11 Jun 2026 07:00:00 GMT
• Muscular dystrophy siRNA from Novartis' Avidity buyout meets biomarker endpoints FirstWord Pharma Thu, 11 Jun 2026 07:00:00 GMT
• Novartis gets win for another Avidity muscular dystrophy AOC pharmaphorum Thu, 11 Jun 2026 07:00:00 GMT
• Sensorion axes hearing loss program; Novartis’ biomarker data in muscular dystrophy Endpoints News Thu, 11 Jun 2026 07:00:00 GMT
• avidity biosciences stock (us05070p1075): pfizer buyout shapes outlook after lvhi income-etf spotlig AD HOC NEWS Mon, 01 Jun 2026 07:00:00 GMT
• novartis ‘always looking’ for further ways to shuttle drugs to brain despite run of recent deals Fierce Biotech Thu, 28 May 2026 12:44:00 GMT
• Novartis buys Avidity Biosciences as part of broader spending spree SWI swissinfo.ch Wed, 27 May 2026 07:00:00 GMT
• REGENXBIO, Novartis, Dyne near FDA submissions in muscular dystrophies BioSpace Tue, 26 May 2026 07:00:00 GMT
• Novartis says Avidity’s science could apply beyond muscular dystrophies Endpoints News Fri, 22 May 2026 07:00:00 GMT
• avidity biosciences stock (us05070p1075): fresh data from muscle disease program keeps investors wat AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• avidity biosciences (rnam) schedule 13g/a: ra capital, kolchinsky, shah update ownership Stock Titan Fri, 15 May 2026 07:00:00 GMT
• avidity biosciences price target announced at $25.00/share by leerink partners Moomoo Fri, 15 May 2026 07:00:00 GMT
• avidity biosciences (rna) short interest & short float | updated may 2026 $rna MarketBeat Fri, 15 May 2026 07:00:00 GMT
• avidity biosciences stock (us05070p1075): biotech innovator in rna therapeutics AD HOC NEWS Thu, 14 May 2026 16:57:03 GMT
• Atrium Therapeutics Reports First Quarter 2026 Financial Results PR Newswire Thu, 14 May 2026 07:00:00 GMT
• rnam price today: avidity biosciences, inc. stock price, quote & chart | mexc MEXC Exchange Sat, 09 May 2026 13:48:21 GMT
• Novartis Reshapes Growth With Biotech Deals And AI Powered R&D Push Yahoo Finance Thu, 30 Apr 2026 07:00:00 GMT
• facioscapulohumeral muscular dystrophy market: pharma pipeline fuels rapid expansion – delveinsight | dyne therapeutics, mirecule,... Barchart.com Wed, 29 Apr 2026 12:36:15 GMT
• Novartis to Spend $70 Million More on R&D Each Month for Avidity Bloomberg.com Tue, 28 Apr 2026 07:00:00 GMT
• avidity shares climb on promising dmd44 trial results for del-zota MSN Mon, 27 Apr 2026 10:40:11 GMT
• novartis to buy u.s. biotech firm avidity biosciences for about $12 billion in cash MSN Sat, 18 Apr 2026 11:25:55 GMT
• novartis to buy u.s. biotech firm avidity biosciences for about $12 billion in cash MSN Fri, 17 Apr 2026 07:29:28 GMT
• which is a better investment, regeneron pharmaceuticals, inc. or avidity biosciences, inc. stock? AAII Wed, 15 Apr 2026 16:49:46 GMT
• who is the ceo of avidity biosciences in 2026? sarah boyce's bio Clay Wed, 15 Apr 2026 07:00:00 GMT
• whats the fair value of avidity biosciences inc stock - 2026 preearnings & weekly return optimization plans baoquankhu1.vn Mon, 13 Apr 2026 17:36:09 GMT
• buybacks report: is avidity biosciences inc a cyclical or defensive stock - 2026 outlook & breakout confirmation trade signals baoquankhu1.vn Fri, 10 Apr 2026 12:47:49 GMT
• travel stocks: can avidity biosciences inc continue delivering strong returns - 2026 valuation update & weekly high conviction ide... baoquankhu1.vn Wed, 08 Apr 2026 04:11:55 GMT
• avidity biosciences stock: novartis $11b buyout — what it means for you AD HOC NEWS Tue, 07 Apr 2026 15:33:11 GMT
• avidity shares climb on promising dmd44 trial results for del-zota MSN Sun, 05 Apr 2026 19:11:44 GMT
• alloy therapeutics appoints alexander titus, ph.d., to lead new vigilance division citybiz Wed, 01 Apr 2026 07:00:00 GMT
• s p trends: will avidity biosciences inc announce a stock split - trend reversal & daily stock trend watchlist baoquankhu1.vn Mon, 30 Mar 2026 17:35:13 GMT
• novartis to acquire excellergy in deal worth up to $2 billion Bloomberg.com Fri, 27 Mar 2026 08:28:07 GMT
• novartis shells out $2 billion for immunology biotech excellergy, in second multi-billion dollar deal in a week CNBC Fri, 27 Mar 2026 07:00:00 GMT
• linklaters advises on usd 11.0 bn financing by novartis of the acquisition of avidity biosciences Legal Desire Fri, 27 Mar 2026 07:00:00 GMT
• buyback watch: should you avoid avidity biosciences inc stock right now - weekly investment recap & ai powered market entry ideas baoquankhu1.vn Wed, 25 Mar 2026 01:30:32 GMT
• biotech camp4 taps veteran cfo as it pushes syngap1 drug to trial Stock Titan Tue, 24 Mar 2026 07:00:00 GMT
• travel stocks: can avidity biosciences inc continue delivering strong returns - portfolio return report & precise swing trade entr... baoquankhu1.vn Sun, 22 Mar 2026 09:22:11 GMT
• atrium therapeutics launches with $270m for rna therapies addressing rare cardio conditions MSN Sun, 22 Mar 2026 01:34:54 GMT
• exit recap: can avidity biosciences inc grow without external funding - 2026 analyst calls & weekly top gainers trade list baoquankhu1.vn Sun, 22 Mar 2026 00:37:53 GMT
• trend report: is avidity biosciences inc part of any major index - 2026 pullback review & ai forecasted entry and exit points baoquankhu1.vn Sat, 21 Mar 2026 21:38:12 GMT
• avidity biosciences joins patient and advocacy communities in ra GuruFocus Thu, 19 Mar 2026 21:44:35 GMT
• Novartis acquisition spin-off pioneers RNA therapeutics for the heart Pharma Voice Thu, 19 Mar 2026 07:00:00 GMT
• novartis to buy u.s. biotech firm avidity biosciences for about $12 billion in cash MSN Wed, 18 Mar 2026 16:32:55 GMT
• myotonic dystrophy pipeline 2026: fda approvals and clinical trials landscape with moa and roa highlights by delveinsight | dyne t... Barchart Wed, 18 Mar 2026 00:32:25 GMT
• novartis' $11b avidity acquisition financing ranks 324th in daily trading amid macro uncertainties Bitget Wed, 18 Mar 2026 00:31:57 GMT
• novartis raises $11 billion bond to fund $12 billion avidity dea GuruFocus Tue, 17 Mar 2026 14:26:33 GMT
• novartis raises $11 billion to fund avidity biosciences deal marketscreener.com Tue, 17 Mar 2026 06:48:45 GMT
• novartis sells $11 billion bonds to fund avidity acquisition BusinessLine Tue, 17 Mar 2026 04:45:15 GMT
• novartis shares rise 0.93% on $12b avidity acquisition as trading volume ranks 302nd in daily activity Bitget Tue, 17 Mar 2026 00:06:00 GMT
• novartis unit files to sell notes to repay loan for avidity biosciences acquisition marketscreener.com Mon, 16 Mar 2026 18:30:23 GMT
• novartis taps debt markets to fund $12 billion avidity acquisition Investing.com Mon, 16 Mar 2026 16:58:58 GMT
• Novartis Offers High-Grade Debt to Fund $12 billion Avidity Deal Bloomberg.com Mon, 16 Mar 2026 07:00:00 GMT
• novartis to buy u.s. biotech firm avidity biosciences for about $12 billion in cash MSN Fri, 13 Mar 2026 18:27:58 GMT
• rnam stock: price, forecast, financials & ai analysis Intellectia AI Thu, 12 Mar 2026 19:15:51 GMT
• New Phase 3 SAFARI44 Trial To Confirm Benefit of Del-Zota in Duchenne Muscular Dystrophy NeurologyLive Wed, 11 Mar 2026 07:00:00 GMT
• $270M RNA Drug Spinout Targets Rare Genetic Cardiomyopathies Genetic Engineering and Biotechnology News Wed, 11 Mar 2026 07:00:00 GMT
• how (rna) movements inform risk allocation models Stock Traders Daily Tue, 10 Mar 2026 04:52:02 GMT
• rnam sec filings - avidity biosciences, inc. 10-k, 10-q, 8-k forms Stock Titan Mon, 09 Mar 2026 10:02:00 GMT
• here's why avidity biosciences stock soared this week (there's more to the deal than you might think) MSN Mon, 09 Mar 2026 00:56:54 GMT
• avidity biosciences (rna) soars to all-time high on looming $12-billion merger with novartis MSN Sun, 08 Mar 2026 23:26:09 GMT
• novartis successfully completes acquisition of avidity biosciences, strengthening late-stage neuroscience pipeline and advancing x... Novartis Sun, 08 Mar 2026 11:57:17 GMT
• novartis successfully completes acquisition of avidity biosciences, strengthening late-stage neuroscience pipeline and advancing x... Novartis Sat, 07 Mar 2026 11:57:48 GMT
• novartis successfully completes acquisition of avidity biosciences, strengthening late-stage neuroscience pipeline and advancing x... Novartis Fri, 06 Mar 2026 23:56:19 GMT
• novartis successfully completes acquisition of avidity biosciences, strengthening late-stage neuroscience pipeline and advancing x... Novartis Thu, 05 Mar 2026 23:55:14 GMT
• why is avidity biosciences stock down 20% pre-market today? Stocktwits Thu, 05 Mar 2026 08:00:00 GMT
• novartis completes $12-bn acquisition of avidity biosciences DCAT Value Chain Insights Thu, 05 Mar 2026 08:00:00 GMT
• novartis successfully completes acquisition of avidity biosciences, strengthening late-stage neuroscience pipeline and advancing x... Novartis Wed, 04 Mar 2026 23:57:12 GMT
• Atrium Therapeutics born from Novartis-Avidity deal to pioneer RNA therapies BioXconomy Wed, 04 Mar 2026 08:00:00 GMT
• novartis successfully completes acquisition of avidity biosciences, strengthening late-stage neuroscience pipeline and advancing x... Novartis Tue, 03 Mar 2026 23:57:34 GMT
• avidity biosciences, inc. (nasdaq:rna) receives average rating of "hold" from analysts MarketBeat Tue, 03 Mar 2026 09:51:14 GMT
• avidity biosciences, inc.(nasdaqgm: rnam) dropped from s&p global bmi index marketscreener.com Tue, 03 Mar 2026 00:23:42 GMT
• avidity biosciences, inc.(nasdaqgm:rnam) dropped from s&p biotechnology select industry index marketscreener.com Tue, 03 Mar 2026 00:23:35 GMT
• New biotech Atrium born out of Novartis/Avidity marriage pharmaphorum Mon, 02 Mar 2026 08:00:00 GMT
• novartis successfully completes acquisition of avidity biosciences, strengthening late-stage neuroscience pipeline and advancing x... marketscreener.com Mon, 02 Mar 2026 08:00:00 GMT
• avidity biosciences reports positive one-year data for del-zota in dmd44 trials Drug Discovery News Mon, 02 Mar 2026 08:00:00 GMT
• atrium tx launches with avidity's rna ticker and cardio assets bioworld.com Mon, 02 Mar 2026 08:00:00 GMT
• avidity biosciences, inc. stock chart | nasdaq: rnam stock price | bitget Bitget Mon, 02 Mar 2026 03:44:24 GMT
• avidity biosciences, inc.(nasdaqgm: rnam) dropped from russell 3000 index marketscreener.com Sun, 01 Mar 2026 23:00:00 GMT
• Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions MedCity News Sun, 01 Mar 2026 08:00:00 GMT
• avidity biosciences, inc.(nasdaqgm:rnam) dropped from russell small cap completeness index marketscreener.com Sun, 01 Mar 2026 08:00:00 GMT
• atrium therapeutics stock pre-market (-4.5%): launch as public company post-spin-off Trefis Sat, 28 Feb 2026 08:00:00 GMT
• novartis completes $12 billion acquisition of avidity biosciences Indian Pharma Post Sat, 28 Feb 2026 08:00:00 GMT
• novartis completes $12 billion avidity biosciences acquisition by investing.com Investing.com Australia Sat, 28 Feb 2026 08:00:00 GMT
• avidity biosciences (nasdaq:rna) reaches new 12-month low - here's what happened MarketBeat Sat, 28 Feb 2026 08:00:00 GMT
• atrium arises from novartis’s avidity buyout Citeline News & Insights Fri, 27 Feb 2026 22:44:30 GMT
• avidity biosciences (rna) director’s options, shares paid out in novartis deal Stock Titan Fri, 27 Feb 2026 20:05:47 GMT
• novartis buyout: avidity biosciences (nasdaq: rna) director’s equity cashed out Stock Titan Fri, 27 Feb 2026 19:56:29 GMT
• avidity biosciences (rna) director disposes options in $72 novartis merger Stock Titan Fri, 27 Feb 2026 19:50:19 GMT
• avidity biosciences (rna) cco reports merger-related stock disposition Stock Titan Fri, 27 Feb 2026 19:47:57 GMT
• operating expenses (excl. cogs) of avidity biosciences, inc. – nasdaq:rnam TradingView Fri, 27 Feb 2026 17:49:21 GMT
• rnam: avidity biosciences - full company report Zacks Investment Research Fri, 27 Feb 2026 14:28:07 GMT
• avidity biosciences inc (rnam-q) stock price and news The Globe and Mail Fri, 27 Feb 2026 14:21:57 GMT
• new rna drugmaker launches with $270m for rare cardiomyopathies Stock Titan Fri, 27 Feb 2026 14:19:00 GMT
• novartis closes $12 billion acquisition of avidity biosciences marketscreener.com Fri, 27 Feb 2026 14:12:20 GMT
• novartis completes $12 billion acquisition of avidity biosciences Indian Pharma Post Fri, 27 Feb 2026 13:00:00 GMT
• s&p 500 futures decline in premarket trading; avidity biosciences, duolingo lag 富途牛牛 Fri, 27 Feb 2026 12:31:00 GMT
• crypto: avidity biosciences (rna) warning: key support level being tested right now InteractiveCrypto Fri, 27 Feb 2026 10:26:19 GMT
• Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates Fierce Biotech Fri, 27 Feb 2026 08:00:00 GMT
• Atrium spins out of Avidity, aiming to target rare heart diseases with RNA BioPharma Dive Fri, 27 Feb 2026 08:00:00 GMT
Avidity Biosciences, Inc(NASDAQ:RNA) 
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment...
Website: http://www.aviditybiosciences.com
Founded: 2012
CEO: Sarah Boyce
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends